Discussion
This review has compiled and summarized the existing observational
studies related to COVID-19 in the pediatric population. The global
incidence of COVID-19 cases has been on the rise. According to the
largest epidemiological survey, the majority of these patients fall
within the age range of 30 to 79 years, comprising 87% of cases. It is
noteworthy that older individuals and those with pre-existing medical
conditions are more susceptible to the adverse effects of the virus. In
contrast, the number of cases among children is relatively low. Patients
under the age of 19 accounted for just 2.2% of the 44,672 confirmed
cases (Wu Z et al., 2020), with only one recorded death. This translates
to an exceptionally low crude mortality rate of 0.1%, which stands in
stark contrast to the higher rates reported in current published data
for adults, ranging from 2.3% to 14.6% ( Chen N et al., 2020,; Huang C
et al., 2020; Wang D et al.;2020).